Rtw Investments as of Dec. 31, 2015
Portfolio Holdings for Rtw Investments
Rtw Investments holds 29 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 17.8 | $53M | 563k | 94.14 | |
| La Jolla Pharmaceuticl Com Par | 9.7 | $29M | 1.1M | 27.00 | |
| Omeros Corporation (OMER) | 9.5 | $28M | 1.8M | 15.73 | |
| Kite Pharma | 8.5 | $25M | 411k | 61.62 | |
| Dicerna Pharmaceuticals | 7.9 | $23M | 2.0M | 11.87 | |
| Achillion Pharmaceuticals | 7.1 | $21M | 2.0M | 10.79 | |
| BioCryst Pharmaceuticals (BCRX) | 6.9 | $20M | 2.0M | 10.32 | |
| Mirati Therapeutics | 4.0 | $12M | 378k | 31.60 | |
| Atara Biotherapeutics | 3.8 | $11M | 426k | 26.41 | |
| Five Prime Therapeutics | 3.5 | $11M | 253k | 41.50 | |
| Agenus | 3.3 | $9.9M | 2.2M | 4.54 | |
| Celldex Therapeutics | 3.3 | $9.8M | 625k | 15.68 | |
| Symmetry Surgical | 2.7 | $7.9M | 863k | 9.20 | |
| Bristol Myers Squibb (BMY) | 2.4 | $7.2M | 104k | 68.79 | |
| Corium Intl | 2.0 | $5.9M | 730k | 8.12 | |
| Global Blood Therapeutics In | 1.9 | $5.6M | 172k | 32.33 | |
| Dyax | 1.4 | $4.3M | 114k | 37.62 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $3.6M | 217k | 16.60 | |
| Lipocine | 0.9 | $2.8M | 216k | 12.93 | |
| Accelr8 Technology | 0.8 | $2.3M | 106k | 21.49 | |
| Invuity | 0.6 | $1.8M | 203k | 8.80 | |
| Cytrx | 0.4 | $1.2M | 462k | 2.65 | |
| Biopharmx | 0.2 | $563k | 371k | 1.52 | |
| Nivalis Therapeutics | 0.1 | $232k | 30k | 7.73 | |
| Meridian Bioscience | 0.0 | $110k | 1.3k | 87.86 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $83k | 6.9k | 11.99 | |
| Nevro (NVRO) | 0.0 | $37k | 142.00 | 260.56 | |
| Berkshire Hathaway (BRK.B) | 0.0 | $7.0k | 50.00 | 140.00 | |
| United States Oil Fund | 0.0 | $7.1k | 14k | 0.51 |
